Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Vascular Access ComplicationSkin and Subcutaneous Tissue DisordersPhlebitisPain
Interventions
PROCEDURE

Control group: silicone adhesive sutureless fixation device

"The standard care consists of:~* Application of hemostasis at the point of insertion for 2 minutes post puncture or until bleeding stops.~* Fix with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and silicone adhesive sutureless fixation device (3300MWA Grip-Lok®)."

PROCEDURE

Intervention Group: zinc oxide sutureless fixation device

"Alternative care consisted of:~* Application of haemostasis at the insertion site for 2 minutes post-puncture or until cessation of bleeding.~* Fixation with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and zinc oxide sutureless fixation device (2200NUZA Grip-Lok®)."

DEVICE

PICC

"The PICC lines used in the study will all be third-generation polyurethane and of the commercial brands:~* PowerPICC™ 4, 5 and 6 Fr from BD~* Maxflo expert™ 5 and 6 Fr from Vygon"

DEVICE

Midline

"The midline lines used in the study will be second or third generation polyurethane and of the commercial brands:~* PowerMidline™ 4 Fr from BD~* Arrow® Midline 4Fr from Arrow"

OTHER

Ultrasound scanner

All punctures will be performed under ultrasound guidance.

Trial Locations (2)

25001

RECRUITING

Arnau de Vilanova Hospital, Lleida

25198

COMPLETED

Hospital Universitari Arnau de Vilanova, Lleida

All Listed Sponsors
collaborator

Official College of Nurses of Lleida

UNKNOWN

collaborator

Institut Catala de Salut

OTHER_GOV

lead

Hospital Arnau de Vilanova

OTHER